Contract YM93
Amerisourcebergen Drug Corp · Department Of Defense · April 4, 2003
Amerisourcebergen Drug Corp was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on April 4, 2003 for $1.15 million of work in medicinal and botanical manufacturing. Performance is in Chesterbrook, PA. This is a task or delivery order issued under parent IDIQ SPE2DX15D3021. It was awarded under full and open competition. The contract has been modified 48 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 25, 2017.
Contract details
- PIID
- YM93
- Parent IDIQ
- SPE2DX15D3021
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chesterbrook, PA
- First action
- April 4, 2003
- Latest action
- May 25, 2017
Description
4538152992!TRICARE WEST
Modification timeline
-
May 25, 2017Base award$17
-
November 23, 2016Base award4536267720!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$644
-
August 12, 2016Base award4535207321!BUR CARBIDE FG STERILE$684
-
July 30, 2014Base award4527962534!TRICARE NORTH$11.2K
-
July 25, 2014Base award4527916926!TRICARE WEST$5.1K
-
April 3, 2014Base award4526900079!TRICARE WEST$7.2K
-
December 12, 2013Base award4526163768!PV PHARM BRANCH, VENDOR DMS, CAGE 1UNBO$62.7K
-
October 23, 2013Base award4525812452!BRACKET,MOUNTING$96.5K
-
June 25, 2013Base award4524831941!BOA$5.0K
-
March 21, 2013Mod 14524020155!BOA$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract YM93?
Contract YM93 is a federal contract awarded to Amerisourcebergen Drug Corp by Department Of Defense on April 4, 2003 for $1.15 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 48 times since the base award.
Who won contract YM93?
Amerisourcebergen Drug Corp won contract YM93 from Department Of Defense.
How much is contract YM93 worth?
Contract YM93 has obligated $1.15 million to date.